Hamlet BioPharma AB publ (XSAT:HAMLET B) Cyclically Adjusted FCF per Share: kr-0.20 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:HAMLET B Hamlet BioPharma AB publ XSAT:HAMLET B
31 GF Score
Price kr5.30
! 2 Warning Signs
View Full Analysis

What is Hamlet BioPharma AB publ Cyclically Adjusted FCF per Share?

Hamlet BioPharma AB publ XSAT:HAMLET B -2.57% 31 Cyclically Adjusted FCF per Share is kr-0.20 as of Jun. 2026. GuruFocus rates XSAT:HAMLET B with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Hamlet BioPharma AB publ's adjusted free cash flow per share for the three months ended in Jun. 2026 was kr-0.048. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-0.20 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-09-05), Hamlet BioPharma AB publ's current stock price is kr5.30. Hamlet BioPharma AB publ's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was kr-0.20. Hamlet BioPharma AB publ's Cyclically Adjusted Price-to-FCF of today is .


Hamlet BioPharma AB publ  (XSAT:HAMLET B) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Hamlet BioPharma AB publ Cyclically Adjusted FCF per Share Related Terms


Hamlet BioPharma AB publ Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Hamlet BioPharma AB publ's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamlet BioPharma AB publ Cyclically Adjusted FCF per Share Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.20 -0.22 -0.20

Hamlet BioPharma AB publ Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 -0.19 -0.19 -0.20 -0.20

XSAT:HAMLET B vs VRTX, REGN, MRNA: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Hamlet BioPharma AB publ's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamlet BioPharma AB publ Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's Cyclically Adjusted Price-to-FCF falls into.


XSAT:HAMLET B
31GF Score
Hamlet BioPharma AB publ XSAT:HAMLET B
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hamlet BioPharma AB publ Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hamlet BioPharma AB publ's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.048/134.6100*134.6100
=-0.048

Current CPI (Jun. 2026) = 134.6100.

Hamlet BioPharma AB publ Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.017 101.138 -0.023
201612 -0.030 102.022 -0.040
201703 -0.029 102.022 -0.038
201706 -0.032 102.752 -0.042
201709 -0.046 103.279 -0.060
201712 -0.036 103.793 -0.047
201803 -0.041 103.962 -0.053
201806 -0.045 104.875 -0.058
201809 -0.032 105.679 -0.041
201812 -0.033 105.912 -0.042
201903 -0.032 105.886 -0.041
201906 -0.057 106.742 -0.072
201909 -0.056 107.214 -0.070
201912 -0.060 107.766 -0.075
202003 -0.033 106.563 -0.042
202006 -0.073 107.498 -0.091
202009 -0.002 107.635 -0.003
202012 -0.053 108.296 -0.066
202103 -0.010 108.360 -0.012
202106 0.011 108.928 0.014
202109 -0.038 110.338 -0.046
202112 -0.037 112.486 -0.044
202203 -0.047 114.825 -0.055
202206 -0.056 118.384 -0.064
202209 -0.058 122.296 -0.064
202212 -0.043 126.365 -0.046
202303 -0.044 127.042 -0.047
202306 -0.025 129.407 -0.026
202309 -0.055 130.224 -0.057
202312 -0.052 131.912 -0.053
202403 -0.072 132.205 -0.073
202406 -0.060 132.716 -0.061
202409 -0.037 132.304 -0.038
202412 -0.071 132.987 -0.072
202503 -0.058 132.825 -0.059
202506 -0.052 133.699 -0.052
202509 -0.063 133.480 -0.064
202512 -0.063 133.390 -0.064
202603 -0.063 133.560 -0.063
202606 -0.048 134.610 -0.048

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr-0.20 mean?
Hamlet BioPharma AB publ (XSAT:HAMLET B) has a Cyclically Adjusted FCF per Share of kr-0.20 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Hamlet BioPharma AB publ and its competitors.
Is Hamlet BioPharma AB publ's Cyclically Adjusted FCF per Share too high?
Hamlet BioPharma AB publ's current Cyclically Adjusted FCF per Share is kr-0.20. Overall, Hamlet BioPharma AB publ has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Hamlet BioPharma AB publ's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Hamlet BioPharma AB publ's Cyclically Adjusted FCF per Share of kr-0.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Hamlet BioPharma AB publ and its competitors. Hamlet BioPharma AB publ's current Cyclically Adjusted FCF per Share is kr-0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamlet BioPharma AB publ stock overvalued right now?
Hamlet BioPharma AB publ (XSAT:HAMLET B) has a current Cyclically Adjusted FCF per Share of kr-0.20. The current Cyclically Adjusted FCF per Share is kr-0.20. Hamlet BioPharma AB publ's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Hamlet BioPharma AB publ (XSAT:HAMLET B), the current Cyclically Adjusted FCF per Share is kr-0.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hamlet BioPharma AB publ Business Description

Other Exchanges 7ZT:Germany
Address Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.
31GF Score

Get the complete analysis for XSAT:HAMLET B

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.30
Price